Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 68 entries
Sorted by: Best Match Show Resources per page
[Erratum to "The way forward in transfusion medicine, from a French perspective…" [Transfus. Clin. Biol. (25)(1) (2018)]].

Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine

Garraud O, Folléa G, Lassale B, Pirenne F.
PMID: 29573907
Transfus Clin Biol. 2018 May;25(2):148. doi: 10.1016/j.tracli.2018.02.002. Epub 2018 Mar 21.

No abstract available.

Cite
Garraud O, Folléa G, Lassale B, et al. Erratum à l’article : “The way forward in transfusion medicine, from a French perspective…” [Transfus. Clin. Biol. (25)(1) (2018)]. [Erratum to "The way forward in transfusion medicine, from a French perspective…" [Transfus. Clin. Biol. (25)(1) (2018)]]. Transfus Clin Biol. 2018;25(2):148doi: 10.1016/j.tracli.2018.02.002.
Garraud, O., Folléa, G., Lassale, B., & Pirenne, F. (2018). Erratum à l’article : “The way forward in transfusion medicine, from a French perspective…” [Transfus. Clin. Biol. (25)(1) (2018)]. [Erratum to "The way forward in transfusion medicine, from a French perspective…" [Transfus. Clin. Biol. (25)(1) (2018)]]. Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine, 25(2), 148. https://doi.org/10.1016/j.tracli.2018.02.002
Garraud, O, et al. "Erratum à l’article : “The way forward in transfusion medicine, from a French perspective…” [Transfus. Clin. Biol. (25)(1) (2018)]." [Erratum to "The way forward in transfusion medicine, from a French perspective…" [Transfus. Clin. Biol. (25)(1) (2018)]]. Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine vol. 25,2 (2018): 148. doi: https://doi.org/10.1016/j.tracli.2018.02.002
Garraud O, Folléa G, Lassale B, Pirenne F. Erratum à l’article : “The way forward in transfusion medicine, from a French perspective…” [Transfus. Clin. Biol. (25)(1) (2018)]. [Erratum to "The way forward in transfusion medicine, from a French perspective…" [Transfus. Clin. Biol. (25)(1) (2018)]]. Transfus Clin Biol. 2018 May;25(2):148. doi: 10.1016/j.tracli.2018.02.002. Epub 2018 Mar 21. French. PMID: 29573907.
Copy Download .nbib Format: NLM
RETRACTED: Delayed Hemolytic Transfusion Reaction and Hyperhemolysis Syndrome without Detectable Alloantibodies or Autoantibodies in a Patient with Sickle Cell Disease: A Fatal Case Report and Literature Review.

Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine

Nsimba B.
PMID: 29174516
Transfus Clin Biol. 2017 Nov 22; doi: 10.1016/j.tracli.2017.10.008. Epub 2017 Nov 22.

L'éditeur a le regret de vous informer que cet article a déjà été publié dans: Journal of Blood Disorders & Transfusion, 2017, 8:4. DOI: 10.4172/2155-9864.1000388. Cette seconde publication faite par erreur a été retirée.

Cite
Nsimba B. RETRACTED: Delayed Hemolytic Transfusion Reaction and Hyperhemolysis Syndrome without Detectable Alloantibodies or Autoantibodies in a Patient with Sickle Cell Disease: A Fatal Case Report and Literature Review. Transfus Clin Biol. 2017;doi: 10.1016/j.tracli.2017.10.008.
Nsimba, B. (2017). RETRACTED: Delayed Hemolytic Transfusion Reaction and Hyperhemolysis Syndrome without Detectable Alloantibodies or Autoantibodies in a Patient with Sickle Cell Disease: A Fatal Case Report and Literature Review. Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine, . https://doi.org/10.1016/j.tracli.2017.10.008
Nsimba, Basile. "RETRACTED: Delayed Hemolytic Transfusion Reaction and Hyperhemolysis Syndrome without Detectable Alloantibodies or Autoantibodies in a Patient with Sickle Cell Disease: A Fatal Case Report and Literature Review." Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine vol. (2017). doi: https://doi.org/10.1016/j.tracli.2017.10.008
Nsimba B. RETRACTED: Delayed Hemolytic Transfusion Reaction and Hyperhemolysis Syndrome without Detectable Alloantibodies or Autoantibodies in a Patient with Sickle Cell Disease: A Fatal Case Report and Literature Review. Transfus Clin Biol. 2017 Nov 22; doi: 10.1016/j.tracli.2017.10.008. Epub 2017 Nov 22. PMID: 29174516.
Copy Download .nbib Format: NLM
Reporting of delayed adverse donor reactions in whole blood donors: Just the tip of an iceberg!.

Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine

Kaur S, Mittal K, Kaur R, Kaur G, Kaur P, Sood T.
PMID: 34856397
Transfus Clin Biol. 2021 Nov 29; doi: 10.1016/j.tracli.2021.11.003. Epub 2021 Nov 29.

BACKGROUND AND OBJECTIVES: The study was planned to determine the incidence and analyze how various epidemiological factors tend to be associated with delayed adverse donor reactions (ADR).MATERIAL AND METHODS: The prospective observational study was conducted in Department of Transfusion...

Cite
Kaur S, Mittal K, Kaur R, et al. Reporting of delayed adverse donor reactions in whole blood donors: Just the tip of an iceberg!. Transfus Clin Biol. 2021;doi: 10.1016/j.tracli.2021.11.003.
Kaur, S., Mittal, K., Kaur, R., Kaur, G., Kaur, P., & Sood, T. (2021). Reporting of delayed adverse donor reactions in whole blood donors: Just the tip of an iceberg!. Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine, . https://doi.org/10.1016/j.tracli.2021.11.003
Kaur, S, et al. "Reporting of delayed adverse donor reactions in whole blood donors: Just the tip of an iceberg!." Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine vol. (2021). doi: https://doi.org/10.1016/j.tracli.2021.11.003
Kaur S, Mittal K, Kaur R, Kaur G, Kaur P, Sood T. Reporting of delayed adverse donor reactions in whole blood donors: Just the tip of an iceberg!. Transfus Clin Biol. 2021 Nov 29; doi: 10.1016/j.tracli.2021.11.003. Epub 2021 Nov 29. PMID: 34856397.
Copy Download .nbib Format: NLM
The Role of Funduscopy in Severe Thrombocytopenia: A Prospective Study.

Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine

Saade MC, Haddad FG, Sukkarieh G, Mechleb N, Waked N.
PMID: 34923149
Transfus Clin Biol. 2021 Dec 16; doi: 10.1016/j.tracli.2021.11.004. Epub 2021 Dec 16.

PURPOSE: Platelet transfusions for patients suffering from severe thrombocytopenia are regulated by clinical bleedings and platelet counts. The aim of this study was to assess the prevalence of retinal hemorrhage in patients with hematologic and oncologic malignancies and severe...

Cite
Saade MC, Haddad FG, Sukkarieh G, et al. The Role of Funduscopy in Severe Thrombocytopenia: A Prospective Study. Transfus Clin Biol. 2021;doi: 10.1016/j.tracli.2021.11.004.
Saade, M. C., Haddad, F. G., Sukkarieh, G., Mechleb, N., & Waked, N. (2021). The Role of Funduscopy in Severe Thrombocytopenia: A Prospective Study. Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine, . https://doi.org/10.1016/j.tracli.2021.11.004
Saade, Marie Christelle, et al. "The Role of Funduscopy in Severe Thrombocytopenia: A Prospective Study." Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine vol. (2021). doi: https://doi.org/10.1016/j.tracli.2021.11.004
Saade MC, Haddad FG, Sukkarieh G, Mechleb N, Waked N. The Role of Funduscopy in Severe Thrombocytopenia: A Prospective Study. Transfus Clin Biol. 2021 Dec 16; doi: 10.1016/j.tracli.2021.11.004. Epub 2021 Dec 16. PMID: 34923149.
Copy Download .nbib Format: NLM
Is high hemoglobin a hindrance factor for blood donation? A pilot observational study from the coastal region of India.

Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine

Kandasamy D, Shastry S, O'Brien SF.
PMID: 34856398
Transfus Clin Biol. 2021 Nov 29; doi: 10.1016/j.tracli.2021.11.002. Epub 2021 Nov 29.

BACKGROUND: Blood donors with high Hb are often deferred for the presumed risk of polycythemia vera (PV). However, adequate data to substantiate or refute this hypothesis is lacking.METHODOLOGY: We conducted an observational study on blood donors found to have...

Cite
Kandasamy D, Shastry S, O'Brien SF. Is high hemoglobin a hindrance factor for blood donation? A pilot observational study from the coastal region of India. Transfus Clin Biol. 2021;doi: 10.1016/j.tracli.2021.11.002.
Kandasamy, D., Shastry, S., & O'Brien, S. F. (2021). Is high hemoglobin a hindrance factor for blood donation? A pilot observational study from the coastal region of India. Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine, . https://doi.org/10.1016/j.tracli.2021.11.002
Kandasamy, D, et al. "Is high hemoglobin a hindrance factor for blood donation? A pilot observational study from the coastal region of India." Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine vol. (2021). doi: https://doi.org/10.1016/j.tracli.2021.11.002
Kandasamy D, Shastry S, O'Brien SF. Is high hemoglobin a hindrance factor for blood donation? A pilot observational study from the coastal region of India. Transfus Clin Biol. 2021 Nov 29; doi: 10.1016/j.tracli.2021.11.002. Epub 2021 Nov 29. PMID: 34856398.
Copy Download .nbib Format: NLM
Platelet transfusion practice and related transfusion reactions in a large teaching hospital.

Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine

Liker M, Bojanić I, Plenković F, Lukić M, Tomac G, Raos M, Ćepulić BG.
PMID: 34411746
Transfus Clin Biol. 2021 Aug 16; doi: 10.1016/j.tracli.2021.08.004. Epub 2021 Aug 16.

BACKGROUND: Platelet transfusion practice varies widely since many aspects of platelet concentrate (PC) use have not been definitively determined. The objectives of this retrospective study were to present platelet transfusion practice and evaluate PC and patient characteristics, as well...

Cite
Liker M, Bojanić I, Plenković F, et al. Platelet transfusion practice and related transfusion reactions in a large teaching hospital. Transfus Clin Biol. 2021;doi: 10.1016/j.tracli.2021.08.004.
Liker, M., Bojanić, I., Plenković, F., Lukić, M., Tomac, G., Raos, M., & Ćepulić, B. G. (2021). Platelet transfusion practice and related transfusion reactions in a large teaching hospital. Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine, . https://doi.org/10.1016/j.tracli.2021.08.004
Liker, M, et al. "Platelet transfusion practice and related transfusion reactions in a large teaching hospital." Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine vol. (2021). doi: https://doi.org/10.1016/j.tracli.2021.08.004
Liker M, Bojanić I, Plenković F, Lukić M, Tomac G, Raos M, Ćepulić BG. Platelet transfusion practice and related transfusion reactions in a large teaching hospital. Transfus Clin Biol. 2021 Aug 16; doi: 10.1016/j.tracli.2021.08.004. Epub 2021 Aug 16. PMID: 34411746.
Copy Download .nbib Format: NLM
A quick "Can I donate blood" self-assessment tool amid the COVID-19 outbreak.

Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine

Raturi M.
PMID: 32417113
Transfus Clin Biol. 2020 Aug;27(3):169-170. doi: 10.1016/j.tracli.2020.04.004. Epub 2020 May 07.

No abstract available.

Cite
Raturi M. A quick "Can I donate blood" self-assessment tool amid the COVID-19 outbreak. Transfus Clin Biol. 2020;27(3):169-170doi: 10.1016/j.tracli.2020.04.004.
Raturi, M. (2020). A quick "Can I donate blood" self-assessment tool amid the COVID-19 outbreak. Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine, 27(3), 169-170. https://doi.org/10.1016/j.tracli.2020.04.004
Raturi, M. "A quick "Can I donate blood" self-assessment tool amid the COVID-19 outbreak." Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine vol. 27,3 (2020): 169-170. doi: https://doi.org/10.1016/j.tracli.2020.04.004
Raturi M. A quick "Can I donate blood" self-assessment tool amid the COVID-19 outbreak. Transfus Clin Biol. 2020 Aug;27(3):169-170. doi: 10.1016/j.tracli.2020.04.004. Epub 2020 May 07. PMID: 32417113; PMCID: PMC7204741.
Copy Download .nbib Format: NLM
Haploidentical haematopoietic stem cell transplantation for the treatment of severe aplastic anaemia patients with high-risk factors who lack an HLA-matched sibling donor.

Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine

Niu YY, Ma LM, Wang T.
PMID: 34343707
Transfus Clin Biol. 2021 Jul 31; doi: 10.1016/j.tracli.2021.07.007. Epub 2021 Jul 31.

This study aimed to analyse the efficacy of haploidentical donor (HID) haematopoietic stem cell transplantation as a first-line treatment for severe aplastic anaemia (SAA) with high-risk factors (infection or very severe aplastic anaemia,VSAA) in patients who lack an HLA-matched...

Cite
Niu YY, Ma LM, Wang T. Haploidentical haematopoietic stem cell transplantation for the treatment of severe aplastic anaemia patients with high-risk factors who lack an HLA-matched sibling donor. Transfus Clin Biol. 2021;doi: 10.1016/j.tracli.2021.07.007.
Niu, Y. Y., Ma, L. M., & Wang, T. (2021). Haploidentical haematopoietic stem cell transplantation for the treatment of severe aplastic anaemia patients with high-risk factors who lack an HLA-matched sibling donor. Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine, . https://doi.org/10.1016/j.tracli.2021.07.007
Niu, Y-Y, et al. "Haploidentical haematopoietic stem cell transplantation for the treatment of severe aplastic anaemia patients with high-risk factors who lack an HLA-matched sibling donor." Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine vol. (2021). doi: https://doi.org/10.1016/j.tracli.2021.07.007
Niu YY, Ma LM, Wang T. Haploidentical haematopoietic stem cell transplantation for the treatment of severe aplastic anaemia patients with high-risk factors who lack an HLA-matched sibling donor. Transfus Clin Biol. 2021 Jul 31; doi: 10.1016/j.tracli.2021.07.007. Epub 2021 Jul 31. PMID: 34343707.
Copy Download .nbib Format: NLM
Correlation between ABO blood group and neutralizing anti-SARS-CoV-2 antibody titers in convalescent plasma donations.

Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine

Franchini M, Mengoli C, Ballotari A, Glingani C.
PMID: 34690072
Transfus Clin Biol. 2021 Oct 12; doi: 10.1016/j.tracli.2021.10.002. Epub 2021 Oct 12.

No abstract available.

Cite
Franchini M, Mengoli C, Ballotari A, et al. Correlation between ABO blood group and neutralizing anti-SARS-CoV-2 antibody titers in convalescent plasma donations. Transfus Clin Biol. 2021;doi: 10.1016/j.tracli.2021.10.002.
Franchini, M., Mengoli, C., Ballotari, A., & Glingani, C. (2021). Correlation between ABO blood group and neutralizing anti-SARS-CoV-2 antibody titers in convalescent plasma donations. Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine, . https://doi.org/10.1016/j.tracli.2021.10.002
Franchini, M, et al. "Correlation between ABO blood group and neutralizing anti-SARS-CoV-2 antibody titers in convalescent plasma donations." Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine vol. (2021). doi: https://doi.org/10.1016/j.tracli.2021.10.002
Franchini M, Mengoli C, Ballotari A, Glingani C. Correlation between ABO blood group and neutralizing anti-SARS-CoV-2 antibody titers in convalescent plasma donations. Transfus Clin Biol. 2021 Oct 12; doi: 10.1016/j.tracli.2021.10.002. Epub 2021 Oct 12. PMID: 34690072; PMCID: PMC8507567.
Copy Download .nbib Format: NLM
Greenish colour of single donor apheresis platelet - is it bad? A tricky decision in the resource constraint situation.

Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine

Tripathi PP, Kumawat V, Vittal AV.
PMID: 34799241
Transfus Clin Biol. 2021 Oct 21; doi: 10.1016/j.tracli.2021.10.006. Epub 2021 Oct 21.

No abstract available.

Cite
Tripathi PP, Kumawat V, Vittal AV. Greenish colour of single donor apheresis platelet - is it bad? A tricky decision in the resource constraint situation. Transfus Clin Biol. 2021;doi: 10.1016/j.tracli.2021.10.006.
Tripathi, P. P., Kumawat, V., & Vittal, A. V. (2021). Greenish colour of single donor apheresis platelet - is it bad? A tricky decision in the resource constraint situation. Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine, . https://doi.org/10.1016/j.tracli.2021.10.006
Tripathi, P P, et al. "Greenish colour of single donor apheresis platelet - is it bad? A tricky decision in the resource constraint situation." Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine vol. (2021). doi: https://doi.org/10.1016/j.tracli.2021.10.006
Tripathi PP, Kumawat V, Vittal AV. Greenish colour of single donor apheresis platelet - is it bad? A tricky decision in the resource constraint situation. Transfus Clin Biol. 2021 Oct 21; doi: 10.1016/j.tracli.2021.10.006. Epub 2021 Oct 21. PMID: 34799241.
Copy Download .nbib Format: NLM
[Gene therapy in beta-thalassemia].

Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine

Thuret I.
PMID: 34500092
Transfus Clin Biol. 2021 Nov;28(4):405-406. doi: 10.1016/j.tracli.2021.09.001. Epub 2021 Sep 06.

No abstract available.

Cite
Thuret I. Place de la thérapie génique dans la bêta-thalassémie. [Gene therapy in beta-thalassemia]. Transfus Clin Biol. 2021;28(4):405-406doi: 10.1016/j.tracli.2021.09.001.
Thuret, I. (2021). Place de la thérapie génique dans la bêta-thalassémie. [Gene therapy in beta-thalassemia]. Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine, 28(4), 405-406. https://doi.org/10.1016/j.tracli.2021.09.001
Thuret, I. "Place de la thérapie génique dans la bêta-thalassémie." [Gene therapy in beta-thalassemia]. Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine vol. 28,4 (2021): 405-406. doi: https://doi.org/10.1016/j.tracli.2021.09.001
Thuret I. Place de la thérapie génique dans la bêta-thalassémie. [Gene therapy in beta-thalassemia]. Transfus Clin Biol. 2021 Nov;28(4):405-406. doi: 10.1016/j.tracli.2021.09.001. Epub 2021 Sep 06. French. PMID: 34500092.
Copy Download .nbib Format: NLM
COVID-19, transfusion, and publishing ethics.

Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine

Garraud O.
PMID: 33161953
Transfus Clin Biol. 2020 Nov;27(4):201-202. doi: 10.1016/j.tracli.2020.10.002.

No abstract available.

Cite
Garraud O. COVID-19, transfusion, and publishing ethics. Transfus Clin Biol. 2020;27(4):201-202doi: 10.1016/j.tracli.2020.10.002.
Garraud, O. (2020). COVID-19, transfusion, and publishing ethics. Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine, 27(4), 201-202. https://doi.org/10.1016/j.tracli.2020.10.002
Garraud, O. "COVID-19, transfusion, and publishing ethics." Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine vol. 27,4 (2020): 201-202. doi: https://doi.org/10.1016/j.tracli.2020.10.002
Garraud O. COVID-19, transfusion, and publishing ethics. Transfus Clin Biol. 2020 Nov;27(4):201-202. doi: 10.1016/j.tracli.2020.10.002. PMID: 33161953.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 68 entries